The present investigation uses Somatosensory Evoked Potentials (SEPs) to assess spinal cord function in 50 patients undergoing cervical decompression. The primary objective of this study is to determine the relationship between preoperative, intraoperative and postoperative SEPs, and the neurological outcome of patients following cervical spinal cord decompression. An additional focus is on the effect of bolus and continuous infusion of muscle relaxants (vercuronium bromide) on the SEPs. Preoperatively, the patients will undergo a standardized neurological examination, as well as an evoked potentials recording. The median nerve at the wrist will be stimulated and clavicular (Erb's), cervical (C2 and C7), and cortical (contralateral cortex) evoked potentials will be obtained. The recordings will be taken at the Erb's and contralateral cortex. After baseline recording is obtained, one group (N=25) will receive an intravenous bolus of vercuronium (0. 1mg/kg), and the other group (N=25) will receive continuous infusion (0.9-1 .7ug/kg/min) of vercuronium during their operative procedures. Ten minutes after administration of vercuronium, SEPs will be recorded in each group. SEPs will be monitored and evaluated during essential stages, as well as at the end of the operative procedures. Three months postoperatively another set of SEPs will be performed. The protocol will be identical with the preoperative one. The patients also will undergo a follow up neurological examination.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
1M01RR010284-01A1
Application #
5225839
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Christensen, Kurt D; Uhlmann, Wendy R; Roberts, J Scott et al. (2018) A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone. Genet Med 20:132-141
Doumatey, Ayo P; He, William J; Gaye, Amadou et al. (2018) Circulating MiR-374a-5p is a potential modulator of the inflammatory process in obesity. Sci Rep 8:7680
Guan, Yue; Roter, Debra L; Wolff, Jennifer L et al. (2018) The impact of genetic counselors' use of facilitative strategies on cognitive and emotional processing of genetic risk disclosure for Alzheimer's disease. Patient Educ Couns 101:817-823
Mullins, Tanya L Kowalczyk; Li, Su X; Bethel, James et al. (2018) Sexually transmitted infections and immune activation among HIV-infected but virally suppressed youth on antiretroviral therapy. J Clin Virol 102:7-11
Faruque, Mezbah U; Chen, Guanjie; Doumatey, Ayo P et al. (2017) Transferability of genome-wide associated loci for asthma in African Americans. J Asthma 54:1-8
Guan, Yue; Roter, Debra L; Erby, Lori H et al. (2017) Disclosing genetic risk of Alzheimer's disease to cognitively impaired patients and visit companions: Findings from the REVEAL Study. Patient Educ Couns 100:927-935
Nandakumar, Priyanka; Lee, Dongwon; Richard, Melissa A et al. (2017) Rare coding variants associated with blood pressure variation in 15?914 individuals of African ancestry. J Hypertens 35:1381-1389
Lieberman, Richard; Armeli, Stephen; Scott, Denise M et al. (2016) FKBP5 genotype interacts with early life trauma to predict heavy drinking in college students. Am J Med Genet B Neuropsychiatr Genet 171:879-87
Christensen, Kurt D; Roberts, J Scott; Whitehouse, Peter J et al. (2016) Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial. Ann Intern Med 164:155-63
Armeli, Stephen; O'Hara, Ross E; Covault, Jon et al. (2016) Episode-specific drinking-to-cope motivation and next-day stress-reactivity. Anxiety Stress Coping 29:673-84

Showing the most recent 10 out of 205 publications